| mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.9 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0066 |
0.9 |
| mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
| mRNA |
Platin |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.9 |
| mRNA |
Pazopanib |
GDSC1000 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
| mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.9 |
| mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.9 |
| mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.9 |
| mRNA |
MS-275 |
FIMM |
pan-cancer |
AAC |
0.024 |
0.9 |